Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

X’s director of engineering, Haofei Wang, has suddenly left the company, according to sources with knowledge of the matter.